Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GREGG/KENNEDY COMPROMISE ON FDA DRUG/DEVICE EXPORT REFORM BILL PASSES SENATE LABOR COMMITTEE BY 16-0 VOTE; MEASURE LISTS SPECIFIC COUNTRIES

Executive Summary

A compromise FDA drug/device export bill sponsored by Sens. Gregg (R-N.H.) and Kennedy (D-Mass.), the "FDA Export Reform & Enhancement Act of 1995" (S 593), was approved unanimously by the 16-member Labor & Human Resources Committee during an Aug. 2 mark-up. The compromise bill lists specific countries to which unapproved drugs and devices could be exported without FDA export approval.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026631

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel